Your session is about to expire
← Back to Search
Silicone Taping for Abdominal Scars
N/A
Recruiting
Led By Jason G Williams, MD
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
undergoing de novo abdominoplasty procedures as part of their breast reconstruction
Be older than 18 years old
Must not have
patients who are unable to care for their incisions
patients with scleroderma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month follow up
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if silicone tape can make scars look better after breast reconstruction surgery. Patients will use the tape on part of their surgical scar. The study will check the scars over time to see if the tape helps. Silicone materials, including tapes and implants, have been widely used in breast reconstruction surgeries to improve outcomes and patient satisfaction.
Who is the study for?
This trial is for individuals getting new abdominoplasty as part of breast reconstruction. It's not suitable for those with scleroderma, open wounds or infections at the surgery site, inability to care for incisions, current smokers, steroid users, or a history of collagen disease, connective tissue disorders (like psoriasis or lupus), or silicone adhesive allergies.
What is being tested?
The study tests if silicone tape can improve the appearance of scars after abdominoplasty compared to no dressing. Participants will have silicone tape applied to half their surgical scar two weeks post-operation and will be monitored over time to assess scar healing.
What are the potential side effects?
Potential side effects may include skin irritation or allergic reactions specific to those sensitive to adhesives or silicone. However, since it's a non-invasive treatment, severe side effects are unlikely.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am having a tummy tuck as part of my breast reconstruction.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot take care of my surgical wounds by myself.
Select...
I have scleroderma.
Select...
I am currently taking steroids.
Select...
I have signs of wound reopening or infection that required changes to my wound care.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month follow up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Patient and Observer Scar Assessment Scale (PSAS & OSAS) System
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Silicone tapeExperimental Treatment1 Intervention
Adult subjects will act as their own control and will be randomized to have silicone tape applied to one half of their abdominoplasty incision. Patients will apply silicone tape on a daily basis, with each piece lasting 24 hours. Tape may be removed for showers and replied after drying. Total length of treatment will be two and a half months.
Group II: No dressingActive Control1 Intervention
Control treatment using the current standard of care at our institution to the other half, which is no dressing after the initial two week post-op period, will be used on the other half of the incision for comparison. Each individual patient will act as their own control.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for scarring, such as silicone tape, work primarily through hydration and occlusion. Silicone tape helps to hydrate the scar tissue, which can soften and flatten the scar, making it less noticeable.
The occlusive nature of the tape also protects the scar from external irritants and reduces collagen production, which can prevent excessive scar formation. These mechanisms are crucial for scarring patients as they can significantly improve the appearance and texture of scars, enhancing both aesthetic outcomes and patient confidence.
Platelet-rich plasma in noninvasive procedures for atrophic acne scars: A systematic review and meta-analysis.
Platelet-rich plasma in noninvasive procedures for atrophic acne scars: A systematic review and meta-analysis.
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
288 Previous Clinical Trials
94,530 Total Patients Enrolled
1 Trials studying Scarring
16 Patients Enrolled for Scarring
Jason G Williams, MDPrincipal InvestigatorNova Scotia Health Authority
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of certain autoimmune diseases such as lupus, psoriasis, or connective tissue disorders.I cannot take care of my surgical wounds by myself.I have scleroderma.I am having a tummy tuck as part of my breast reconstruction.You currently smoke cigarettes.I am currently taking steroids.I have signs of wound reopening or infection that required changes to my wound care.You have had a bad reaction to adhesives or are allergic to silicone.
Research Study Groups:
This trial has the following groups:- Group 1: Silicone tape
- Group 2: No dressing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger